Husky Energy Closes Acquisition of Superior Refinery
Nov 08, 2017 21:05 pm UTC| Business
CALGARY, Alberta, Nov. 08, 2017 -- Husky Energy (TSX:HSE) has closed its acquisition of the Superior Refinery, a 50,000 barrel per day refinery located in Superior, Wisconsin. The Superior Refinery increases Husky’s...
Xplore Technologies Reports Increased Profit in Second Quarter
Nov 08, 2017 21:05 pm UTC| Business
AUSTIN, Texas, Nov. 08, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR), a global leader in rugged computing, today reported increased revenue and net income for its fiscal 2018 second quarter, ended September 30,...
CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update
Nov 08, 2017 21:05 pm UTC| Business
- On track to begin first company-sponsored clinical trial of a CRISPR-based therapeutic -- Wholly-owned CRISPR-based CAR-T programs advancing rapidly -- New collaborations enhance work in immuno-oncology and in vivo...
Alarm.com Reports Third Quarter 2017 Results
Nov 08, 2017 21:05 pm UTC| Business
-- SaaS and license revenue of $61.9 million, up 39% year-over-year ---- Total revenue of $90.0 million, up 33% year-over-year ---- GAAP net income of $15.1 million, compared to $2.6 million for the third quarter of 2016...
Woodward Reports Fiscal Year 2017 Results and Fiscal Year 2018 Outlook
Nov 08, 2017 21:05 pm UTC| Business
FORT COLLINS, Colo., Nov. 08, 2017 -- Woodward, Inc. (NASDAQ:WWD) today reported financial results for its 2017 fiscal year and fourth quarter ending September 30, 2017. (All per share amounts are presented on a fully...
National General Holdings Corp. Reports Third Quarter 2017 Results
Nov 08, 2017 21:05 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- National General Holdings Corp. (NASDAQ:NGHC) today reported third quarter 2017 net income of $46.2 million or $0.43 per diluted share, compared to net income of $19.9 million or $0.18 per...
Ovid Therapeutics to Participate at the Stifel 2017 Healthcare Conference
Nov 08, 2017 21:05 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that Jeremy Levin, DPhil, MB...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update